Analysis of regulatory legal acts on organization of pharmaceutical provision of certain categories of citizens with the right to social support
To regulate the pharmaceutical provision of privileged categories of citizens, a legislative framework has been created that determines certain groups of the population and categories of diseases, as well as lists of drugs for preferential drug provision. Currently, there is a separation of drug provision to the federal and regional levels. The article presents an analysis of the legislative framework, which showed that, on the one hand, there is a system for distribution of budget funds in accordance with the established categories of citizens and the current restrictive lists of drugs, on the other hand, there are incompletely resolved contradictions and duplications in legislative acts, which negatively affects the organization of health care in our country. However, regulatory framework constantly changes and renews through approval of new programs of state guarantees, federal lists of medical drugs and other normative documents. Thus, there exist further prospects for refreshment of legislative acts that were approved a long time ago and require harmonization with the current normative-legal framework. There exist legislative and practical problems that still remain unsolved. To solve them, it is necessary to finalize the existing regulatory legal acts or develop a new legislative framework. With this, both ways are a difficult task, on solution of which the life and health of patients depend.